Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum.

The aim of this study was to investigate the influence of pH, buffer species and ionic strength on the release mechanism of chlorpheniramine maleate (CPM) from matrix tablets containing chitosan and xanthan gum prepared by a hot-melt extrusion process. Drug release from hot-melt extruded (HME) tablets containing either chitosan or xanthan gum was pH and buffer species dependent and the release mechanisms were controlled by the solubility and ionic properties of the polymers. All directly compressed (DC) tablets prepared in this study also exhibited pH and buffer species dependent release. In contrast, the HME tablets containing both chitosan and xanthan gum exhibited pH and buffer species independent sustained release. When placed in 0.1N HCl, the HME tablets formed a hydrogel that functioned to retard drug release in subsequent pH 6.8 and 7.4 phosphate buffers even when media contained high ionic strength, whereas tablets without chitosan did not form a hydrogel to retard drug release in 0.1N HCl. The HME tablets containing both chitosan and xanthan gum showed no significant change in drug release rate when stored at 40 degrees C for 1 month, 40 degrees C and 75% relative humidity (40 degrees C/75% RH) for 1 month, and 60 degrees C for 15 days.

[1]  J. Dressman,et al.  Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. , 1997, Journal of pharmaceutical sciences.

[2]  E. S. Ghaly,et al.  In-Vitro Release of Acetaminophen from Sodium Alginate Controlled Release Pellets , 1994 .

[3]  H. Saitǒ,et al.  Interaction of indomethacin with low molecular weight chitosan, and improvements of some pharmaceutical properties of indomethacin by low molecular weight chitosans , 1991 .

[4]  Mansoor Amiji,et al.  Chitosan-based gastrointestinal delivery systems. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[5]  N. Kaniwa,et al.  Development and evaluation of a new peroral test agent GA-test for assessment of gastric acidity. , 1984, Journal of pharmacobio-dynamics.

[6]  T. Nagai,et al.  Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate , 1990 .

[7]  J. Dressman,et al.  Upper Gastrointestinal pH in Seventy-Nine Healthy, Elderly, North American Men and Women , 1993, Pharmaceutical Research.

[8]  T. Chandy,et al.  Chitosan matrix for oral sustained delivery of ampicillin. , 1993, Biomaterials.

[9]  T. Aminabhavi,et al.  Controlled release of clozapine through chitosan microparticles prepared by a novel method. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[10]  K. Deuchi,et al.  Increasing Effect of a Chitosan and Ascorbic Acid Mixture on Fecal Dietary Fat Excretion , 1994 .

[11]  J. Siepmann,et al.  HPMC-Matrices for Controlled Drug Delivery: A New Model Combining Diffusion, Swelling, and Dissolution Mechanisms and Predicting the Release Kinetics , 1999, Pharmaceutical Research.

[12]  Nicholas A. Peppas,et al.  A simple equation for description of solute release II. Fickian and anomalous release from swellable devices , 1987 .

[13]  J. Mcginity,et al.  Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[14]  K. Gupta,et al.  Semi-interpenetrating polymer network beads of crosslinked chitosan–glycine for controlled release of chlorphenramine maleate , 2000 .

[15]  S. Martelli,et al.  Polymers with pH-Dependent Solubility: Possibility of Use in the Formulation of Gastroresistant and Controlled-Release Matrix Tablets , 2000, Drug development and industrial pharmacy.

[16]  A. Nada,et al.  Preparation and evaluation of slow-release pan-coated indomethacin granules. , 1994, Journal of microencapsulation.

[17]  Nicholas A. Peppas,et al.  A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs , 1987 .

[18]  R Morita,et al.  Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS). I. Design Of SCRS and its release controlling factor. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[19]  F. Giordano,et al.  Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: a study on process parameters and in vitro performances. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[20]  H. Petereit,et al.  Properties of enteric coated sodium valproate pellets. , 2003, International journal of pharmaceutics.

[21]  A. Florence,et al.  The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  T. Imai,et al.  Enhancement of Dissolution Rates of Several Drugs by Low-Molecular Chitosan and Alginate , 1990 .

[23]  L. Yahia,et al.  In vitro and in vivo biocompatibility of chitosan-xanthan polyionic complex. , 2000, Journal of biomedical materials research.

[24]  J. Mcginity,et al.  Properties of Tablets Containing Granulations of Ibuprofen and an Acrylic Copolymer Prepared by Thermal Processes , 2001, Pharmaceutical development and technology.

[25]  N A Peppas,et al.  A new model describing the swelling and drug release kinetics from hydroxypropyl methylcellulose tablets. , 1999, Journal of pharmaceutical sciences.

[26]  M. Bogataj,et al.  The influence of magnesium stearate on the characteristics of mucoadhesive microspheres. , 2000, Journal of microencapsulation.

[27]  O. N. El-Gazayerly.  Release of Pentoxifylline from Xanthan Gum Matrix Tablets , 2003, Drug development and industrial pharmacy.

[28]  S. Zustiak,et al.  Hydrogels: Recent Advances , 2018 .

[29]  Mohammed Berrada,et al.  A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  J. Zatz,et al.  Evaluation of Xanthan Gum in the Preparation of Sustained Release Matrix Tablets , 1993 .

[31]  J. Dressman,et al.  Upper Gastrointestinal (GI) pH in Young, Healthy Men and Women , 1990, Pharmaceutical Research.

[32]  J. Plaizier-Vercammen,et al.  Evaluation of Xanthan Cum as a Hydrophilic Matrix for Controlled-Release Dosage form Preparations , 1993 .

[33]  N. Peppas,et al.  Mechanistic analysis of protein delivery from porous poly(vinyl alcohol) systems , 2004 .

[34]  S. Borodkin,et al.  Xanthan Gum and Alginate Based Controlled Release Theophylline Formulations , 1991 .

[35]  S. L. Wright,et al.  Drug diffusion and binding in ionizable interpenetrating networks from poly(vinyl alcohol) and poly(acrylic acid). , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[36]  Buddy D. Ratner,et al.  Biomaterials Science: An Introduction to Materials in Medicine , 1996 .

[37]  J. Newton,et al.  Factors influencing the mechanism of release from sustained release matrix pellets, produced by extrusion/spheronisation , 1993 .

[38]  Paula Heinänen,et al.  In vitro evaluation of microcrystalline chitosan (MCCh) as gel-forming excipient in matrix granules. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[39]  N. Peppas,et al.  Hydrogels in Pharmaceutical Formulations , 1999 .

[40]  A. Mitrevej,et al.  Multiunit Controlled-Release Diclofenac Sodium Capsules Using Complex of Chitosan with Sodium Alginate or Pectin , 2001, Pharmaceutical development and technology.

[41]  M. Tobyn,et al.  Influence of Physiological Variables on the In Vitro Drug-Release Behavior of a Polysaccharide Matrix Controlled-Release System , 2003, Drug development and industrial pharmacy.

[42]  J. Mcginity,et al.  Influence of Thermal Processing on the Properties of Chlorpheniramine Maleate Tablets Containing an Acrylic Polymer , 2002, Pharmaceutical development and technology.

[43]  N A Peppas,et al.  Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles. , 2000, International journal of pharmaceutics.

[44]  정동효.  Xanthan gum의 생산과 응용 , 1978 .

[45]  Yoshiteru Takahashi,et al.  Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS). II. In vitro and in vivo evaluation. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[46]  J. Schwartz,et al.  The Effect of Formulation Composition and Dissolution Parameters on the Gel Strength of Controlled Release Hydrogel Tablets , 2001, Pharmaceutical development and technology.

[47]  N. Peppas,et al.  Structure and Interactions in Covalently and Ionically Crosslinked Chitosan Hydrogels for Biomedical Applications , 2003 .

[48]  Tejraj M. Aminabhavi,et al.  Controlled release of diclofenac sodium from sodium alginate beads crosslinked with glutaraldehyde , 1999 .